| 幽门螺旋杆菌三种药物治疗方案的成本－效果分析 |
| |
| 引用本文： | 潘志浩,李莉. 幽门螺旋杆菌三种药物治疗方案的成本－效果分析[J]. 国际医药卫生导报, 2010, 16(24): 3014-3016. DOI: 10.3760/cma.j.issn.1007-1245.2010.24.023 |
| |
| 作者姓名： | 潘志浩 李莉 |
| |
| 作者单位： | 佛山市顺德区陈村医院,528313 |
| |
| 摘 要： | 目的 评价不同药物组合方案治疗幽门螺旋杆菌感染所产生的经济效果.方法 运用药物经济学成本-效果分析法对抗幽门螺旋杆菌3种治疗方案进行分析评价.结果 A、B、C三种方案的成本-效果比分别是2.03、2.51和2.53.无论是从成本-效果比分析,还是从增量成本-效果比分析,均得出A方案为抗幽门螺旋杆菌感染的最佳方案.结论 药物经济学的成本-效果分析可为临床医生和患者治疗幽门螺旋杆菌感染提供合理和经济的治疗方案.
|
| 关 键 词： | 幽门螺旋杆菌 治疗方案 成本－效果分析 |
Cost-effectiveness analysis on three different therapies for helicobacter pylori infection |
| |
| PAN Zhi-jie,LI Li. Cost-effectiveness analysis on three different therapies for helicobacter pylori infection[J]. International Medicine & Health Guidance News, 2010, 16(24): 3014-3016. DOI: 10.3760/cma.j.issn.1007-1245.2010.24.023 |
| |
| Authors: | PAN Zhi-jie LI Li |
| |
| Affiliation: | (Chencun Hospital of Shunde District in Foshan, Foshan 528313, China;Chencun Hospital of Shunde District in Foshan, Foshan 528313, China) |
| |
| Abstract: | Objective To evaluate the cost-effectiveness analysis (CE) of three therapies for helicobacter pylori (Hp) infection. Methods The CE of three therapies for Hp infection was analyzed by the methods of pharmacoeconomics. Results The CE ratios of three therapies in group A, group B and group C were 1.41, 1.43 and 2.24 respectively. From CE analysis and increasing CE analysis, the therapeutic scheme in group A is the best one. Conclusion The rational and economic therapeutic scheme for Hp infection can he acquired by cliniciansand patients using CE analysis of pharmacoeconomics. |
| |
| Keywords: | Helicobacter pylori Tscheme C-effectiveness analysis |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
